|
- 2015
通用引物SPF1/GP6++与SPF1/GP6+聚合酶链式反应检测多型别人乳头瘤病毒敏感度的比较DOI: 10.3971/j.issn.1000-8578.2015.09.005 Keywords: A New Technique to Treat Early Stage Cervical Cancer,Value of High-risk Human Papilloma Virus Infection in Preliminary Screening of Cervical Cancer,Diagnostic Value of PET/CT for Metastatic Lymph Nodes in Cervical Cancer Patients: A Meta-analysis,Impact of Different Treatment Models on Prognosis and QOL of Patients with Stage ⅡB Cervical Cancer Abstract: 摘要 目的 对比通用引物SPF1/GP6++与SPF1/GP6+ PCR两种方法检测人乳头瘤病毒(HPV)的敏感度和感染型别范围。方法 以包含HPV16全长DNA序列的质粒为模板,应用HPV L1基因型别特异性引物进行PCR扩增,获得15种型别HPV模拟靶基因序列并克隆入pEASY-T1载体,将梯度稀释的重组质粒掺入50 ng正常人基因组DNA,模拟各型别HPV感染的待测样本,对比SPF1/GP6+和SPF1/GP6++两组通用引物的检测敏感度。进一步在68例人宫颈癌组织DNA样本中进行对比验证。结果 与SPF1/GP6+PCR比较,SPF1/GP6++ PCR对HPV11,31,34,39,51,52,53,56,58,61和66型别的检测敏感度提高了1到2个数量级,对于HPV16,18,33和35常见感染型别的检测敏感度相似。应用SPF1/GP6++ PCR检测宫颈癌组织HPV感染的总阳性率为98.5%(67/68),检测到11例双重感染和2例三重感染;而应用SPF1/GP6+ PCR检测的总阳性率为95.6%(65/68),仅检测到7例双重感染。结论 在SPF1/GP6+ PCR基础上建立了SPF1/GP6++ PCR方法,并证实SPF1/GP6++ PCR具有更高的检测敏感度和更广的HPV型别检测范围
|